Clearance Summary
FlexBoardTM, EagleBoardTM, BreastBoard SXTM received FDA 510(k) clearance under submission number K213439, sponsored by Macromedics BV. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2022-06-24.
- Submission: K213439
- Applicant / Sponsor: Macromedics BV
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.5050
- Decision date: 2022-06-24
Classification & Regulation
This clearance is catalogued under FDA product code IYE and 21 CFR 892.5050, within the Radiology review panel as a Class II device.